An affinity chromatography and glycoproteomics workflow to profile the chondroitin sulfate proteoglycans that interact with malarial VAR2CSA in the placenta and in cancer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
An affinity chromatography and glycoproteomics workflow to profile the chondroitin sulfate proteoglycans that interact with malarial VAR2CSA in the placenta and in cancer. / Toledo, Alejandro Gómez; Pihl, Jessica; Spliid, Charlotte B; Persson, Andrea; Nilsson, Jonas; Pereira, Marina Ayres; Gustavsson, Tobias; Choudhary, Swati; Zarni Oo, Htoo; Black, Peter C; Daugaard, Mads; Esko, Jeffrey D; Larson, Göran; Salanti, Ali; Clausen, Thomas Mandel.
I: Glycobiology, Bind 30, Nr. 12, 2020, s. 989-1002.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - An affinity chromatography and glycoproteomics workflow to profile the chondroitin sulfate proteoglycans that interact with malarial VAR2CSA in the placenta and in cancer
AU - Toledo, Alejandro Gómez
AU - Pihl, Jessica
AU - Spliid, Charlotte B
AU - Persson, Andrea
AU - Nilsson, Jonas
AU - Pereira, Marina Ayres
AU - Gustavsson, Tobias
AU - Choudhary, Swati
AU - Zarni Oo, Htoo
AU - Black, Peter C
AU - Daugaard, Mads
AU - Esko, Jeffrey D
AU - Larson, Göran
AU - Salanti, Ali
AU - Clausen, Thomas Mandel
PY - 2020
Y1 - 2020
N2 - Chondroitin sulfate (CS) is the placental receptor for the VAR2CSA malaria protein, expressed at the surface of infected erythrocytes during Plasmodium falciparum infection. Infected cells adhere to syncytiotrophoblasts or get trapped within the intervillous space by binding to a determinant in a 4-O-sulfated CS chains. However, the exact structure of these glycan sequences remains unclear. VAR2CSA-reactive CS is also expressed by tumor cells, making it an attractive target for cancer diagnosis and therapeutics. The identities of the proteoglycans carrying these modifications in placental and cancer tissues remain poorly characterized. This information is clinically relevant since presentation of the glycan chains may be mediated by novel core proteins or by a limited subset of established proteoglycans. To address this question, VAR2CSA-binding proteoglycans were affinity-purified from the human placenta, tumor tissues and cancer cells and analyzed through a specialized glycoproteomics workflow. We show that VAR2CSA-reactive CS chains associate with a heterogenous group of proteoglycans, including novel core proteins. Additionally, this work demonstrates how affinity purification in combination with glycoproteomics analysis can facilitate the characterization of CSPGs with distinct CS epitopes. A similar workflow can be applied to investigate the interaction of CSPGs with other CS binding lectins as well.
AB - Chondroitin sulfate (CS) is the placental receptor for the VAR2CSA malaria protein, expressed at the surface of infected erythrocytes during Plasmodium falciparum infection. Infected cells adhere to syncytiotrophoblasts or get trapped within the intervillous space by binding to a determinant in a 4-O-sulfated CS chains. However, the exact structure of these glycan sequences remains unclear. VAR2CSA-reactive CS is also expressed by tumor cells, making it an attractive target for cancer diagnosis and therapeutics. The identities of the proteoglycans carrying these modifications in placental and cancer tissues remain poorly characterized. This information is clinically relevant since presentation of the glycan chains may be mediated by novel core proteins or by a limited subset of established proteoglycans. To address this question, VAR2CSA-binding proteoglycans were affinity-purified from the human placenta, tumor tissues and cancer cells and analyzed through a specialized glycoproteomics workflow. We show that VAR2CSA-reactive CS chains associate with a heterogenous group of proteoglycans, including novel core proteins. Additionally, this work demonstrates how affinity purification in combination with glycoproteomics analysis can facilitate the characterization of CSPGs with distinct CS epitopes. A similar workflow can be applied to investigate the interaction of CSPGs with other CS binding lectins as well.
U2 - 10.1093/glycob/cwaa039
DO - 10.1093/glycob/cwaa039
M3 - Journal article
C2 - 32337544
VL - 30
SP - 989
EP - 1002
JO - Glycobiology
JF - Glycobiology
SN - 0959-6658
IS - 12
ER -
ID: 252997308